AKT1 and obesity disorder: The aim of this review is to provide an overview of the current knowledge on the mechanisms by which PI3K/Akt signaling regulates obesity-induced inflammation in AT and discuss novel pharmacological strategies to resolve or relapse meta-inflammation.